CAPTRUST Financial Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-67,877
| Closed | -$2.01M | – | 2735 |
|
|
2023
Q4 | $2.01M | Sell |
67,877
-28,501
| -30% | -$568K | 0.01% | 904 |
|
|
2023
Q3 | $1.53M | Buy |
96,378
+35,011
| +57% | +$582K | 0.01% | 974 |
|
|
2023
Q2 | $1.16M | Buy |
61,367
+34,482
| +128% | +$407K | ﹤0.01% | 1117 |
|
|
2023
Q1 | $103K | Sell |
26,885
-423
| -2% | -$1.8K | ﹤0.01% | 2155 |
|
|
2022
Q4 | $135K | Buy |
+27,308
| New | +$148K | ﹤0.01% | 2014 |
|
|
2022
Q3 | – | Sell |
-2,016
| Closed | -$9K | – | 4343 |
|
|
2022
Q2 | $9K | Hold |
2,016
| – | – | ﹤0.01% | 3829 |
|
|
2022
Q1 | $10K | Hold |
2,016
| – | – | ﹤0.01% | 3822 |
|
|
2021
Q4 | $15K | Buy |
2,016
+148
| +8% | +$920 | ﹤0.01% | 3492 |
|
|
2021
Q3 | $11K | Buy |
1,868
+1,122
| +150% | +$6.48K | ﹤0.01% | 3574 |
|
|
2021
Q2 | $5K | Hold |
746
| – | – | ﹤0.01% | 3887 |
|
|
2021
Q1 | $6K | Buy |
746
+498
| +201% | +$4.07K | ﹤0.01% | 3681 |
|
|
2020
Q4 | $2K | Sell |
248
-300
| -55% | -$1.75K | ﹤0.01% | 3177 |
|
|
2020
Q3 | $2K | Hold |
548
| – | – | ﹤0.01% | 2829 |
|
|
2020
Q2 | $3K | Buy |
+548
| New | +$2.33K | ﹤0.01% | 2538 |
|
|
2019
Q4 | – | Sell |
-448
| Closed | -$1K | – | 1895 |
|
|
2019
Q3 | $1K | Hold |
448
| – | – | ﹤0.01% | 1890 |
|
|
2019
Q2 | $1K | Buy |
448
+108
| +32% | +$255 | ﹤0.01% | 1886 |
|
|
2019
Q1 | $1K | Buy |
+340
| New | +$1.47K | ﹤0.01% | 1773 |
|
|
2018
Q1 | – | Sell |
-67
| Closed | – | – | 1395 |
|
|
2017
Q4 | $0 | Buy |
+67
| New | +$413 | ﹤0.01% | 1282 |
|
Other funds holding IMGN
CAPTRUST Financial Advisors's IMGN Position: Q1 2024 in Review
CAPTRUST Financial Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 67,877 shares — an estimated $2.01M sold.
CAPTRUST Financial Advisors first reported a position in IMGN in Q4 2017 and held it in 18 quarters. The position peaked at $2.01M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- CAPTRUST Financial Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 67,877 Immunogen Inc shares in Q1 2024, an estimated $2.01M.
- CAPTRUST Financial Advisors first reported a position in Immunogen Inc in Q4 2017 and held it in 18 quarters.
- CAPTRUST Financial Advisors's Immunogen Inc position peaked at $2.01M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.